Manipulating calcium homeostasis with nanoplatforms for enhanced cancer therapy

Yanlin Feng, Jianlin Wang, Jimin Cao, Fangfang Cao, Xiaoyuan Chen

PDF
Exploration ›› 2024, Vol. 4 ›› Issue (1) : 20230019. DOI: 10.1002/EXP.20230019
REVIEW

Manipulating calcium homeostasis with nanoplatforms for enhanced cancer therapy

Author information +
History +

Abstract

Calcium ions (Ca2+) are indispensable and versatile metal ions that play a pivotal role in regulating cell metabolism, encompassing cell survival, proliferation, migration, and gene expression. Aberrant Ca2+ levels are frequently linked to cell dysfunction and a variety of pathological conditions. Therefore, it is essential tomaintain Ca2+ homeostasis to coordinate body function. Disrupting the balance of Ca2+ levels has emerged as a potential therapeutic strategy for various diseases, and there has been extensive research on integrating this approach into nanoplatforms. In this review, the current nanoplatforms that regulate Ca2+ homeostasis for cancer therapy are first discussed, including both direct and indirect approaches tomanage Ca2+ overload or inhibit Ca2+ signalling. Then, the applications of these nanoplatforms in targeting different cells to regulate their Ca2+ homeostasis for achieving therapeutic effects in cancer treatment are systematically introduced, including tumour cells and immune cells. Finally, perspectives on the further development of nanoplatforms for regulating Ca2+ homeostasis, identifying scientific limitations and future directions for exploitation are offered.

Keywords

Ca2+ inhibition / Ca2+ overload / calcium homeostasis regulation / cancer therapy / immunotherapy

Cite this article

Download citation ▾
Yanlin Feng, Jianlin Wang, Jimin Cao, Fangfang Cao, Xiaoyuan Chen. Manipulating calcium homeostasis with nanoplatforms for enhanced cancer therapy. Exploration, 2024, 4(1): 20230019 https://doi.org/10.1002/EXP.20230019

RIGHTS & PERMISSIONS

2023 2023 The Authors. Exploration published by Henan University and John Wiley & Sons Australia, Ltd.
PDF

Accesses

Citations

Detail

Sections
Recommended

/